Neurorestoration in Parkinson’s disease by cell replacement and endogenous regeneration

Author： Hermann Andreas   Gerlach Manfred   Schwarz Johannes   Storch Alexander  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.4, Iss.2, 2004-02, pp. : 131-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Embryonic stem cells as a cell source for treating Parkinson’s disease

By Fukuda Hitoshi   Takahashi Jun  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 10, 2005-10 ,pp. : 1273-1280

Informa Healthcare

Access to resources Recommend Favorite

Gene therapy for Parkinson’s disease

By Le Hoang N   Frim David M  

Expert Opinion on Biological Therapy, Vol. 2, Iss. 2, 2002-02 ,pp. : 151-161

Informa Healthcare

Access to resources Recommend Favorite

Proteomic approach to studying parkinson’s disease

By Zhang Jing   Goodlett David  

Molecular Neurobiology, Vol. 29, Iss. 3, 2004-06 ,pp. : 271-288

Humana Press, Inc

Access to resources Recommend Favorite

Environmental toxins and α-synuclein in Parkinson’s disease

By Liu Yanying   Yang Hui  

Molecular Neurobiology, Vol. 31, Iss. 1-3, 2005-02 ,pp. : 273-282

Humana Press, Inc

Access to resources Recommend Favorite

Striatal metabotropic glutamate receptors as a target for pharmacotherapy in Parkinson’s disease

By Bonsi P.   Cuomo D.   Picconi B.   Sciamanna G.   Tscherter A.   Tolu M.   Bernardi G.   Calabresi P.   Pisani A.  

Amino Acids, Vol. 32, Iss. 2, 2007-02 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite